Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,658 | 9,601 | 7,151 | 10,951 | 10,574 |
| Receivables | N/A | 77 | 145 | 303 | 44 |
| TOTAL | $9,702 | $10,153 | $7,564 | $11,808 | $10,673 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3 | 3 | 3 | 214 | 655 |
| TOTAL | $3 | $3 | $3 | $214 | $655 |
| Total Assets | $9,705 | $10,155 | $7,567 | $12,022 | $11,327 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,039 | 1,512 | 1,639 | 1,166 | 960 |
| Accrued Expenses | 3,798 | 2,318 | 3,299 | 2,103 | 1,186 |
| TOTAL | $5,836 | $3,830 | $4,937 | $3,269 | $2,146 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,492 | 2,691 | 2,152 | 245 | 74 |
| TOTAL | $1,492 | $2,691 | $2,152 | $245 | $N/A |
| Total Liabilities | $7,329 | $6,521 | $7,089 | $3,514 | $2,146 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,671 | 29,587 | 20,003 | 10,996 | N/A |
| Common Shares | 4 | 3 | 2 | 1 | 1 |
| Retained earnings | -109,631 | -87,235 | -63,980 | -44,207 | -28,438 |
| Other shareholders' equity | -50 | -31 | -16 | -16 | 0 |
| TOTAL | $2,376 | $3,635 | $478 | $8,508 | $9,181 |
| Total Liabilities And Equity | $9,705 | $10,155 | $7,567 | $12,022 | $11,327 |